NQMC Update Service: December 1, 2014 ► Pharmacy Quality Alliance

NQMC Update Service: December 1, 2014

Pharmacy Quality Alliance

• Antipsychotic use in children: percentage of children under age 5 using antipsychotic medications during the measurement period.

• Antipsychotic use in persons with dementia: percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

• Completion rate for comprehensive medication review (CMR): percentage of prescription drug plan members who met eligibility criteria for medication therapy management (MTM) services and who received a CMR during the eligibility period.

• Diabetes - appropriate treatment of hypertension: percentage of patients who were dispensed a medication for diabetes and hypertension that are receiving an ACEI or ARB or direct renin inhibitor medication during the measurement year.

• Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for biguanides.

• Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for dipeptidyl peptidase-IV (DPP-IV) inhibitors.

• Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for sulfonylureas.

• Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for thiazolidinediones.

• Drug-drug interactions: percentage of patients who received a prescription for a target medication during the measurement period and who were dispensed a concurrent prescription for a precipitant medication.

• Medication therapy for persons with asthma: percentage of patients with asthma during the measurement period who were dispensed more than 3 canisters of short acting beta2 agonist inhalers over a 90-day period and who did not receive controller therapy during the same 90-day period (absence of controller therapy).

• Medication therapy for persons with asthma: percentage of patients with persistent asthma who were dispensed more than 3 canisters of a short-acting beta2 agonist inhaler during the same 90-day period (suboptimal control).

• Use of high-risk medications in the elderly: percentage of patients 65 years of age and older who received two or more prescription fills for a high-risk medication during the measurement period.